| NDC Code |
0115-1330-01 |
| Proprietary Name |
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate |
| Package Description |
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1330-01) |
| Product NDC |
0115-1330 |
| Product Type Name |
HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name |
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate |
| Dosage Form Name |
CAPSULE, EXTENDED RELEASE |
| Route Name |
ORAL |
| Start Marketing Date |
20090930 |
| Marketing Category Name |
NDA AUTHORIZED GENERIC |
| Labeler Name |
Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Substance Name |
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE |
| Strength Number |
3.75; 3.75; 3.75; 3.75 |
| Strength Unit |
mg/1; mg/1; mg/1; mg/1 |
| Pharmaceutical Classes |
Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |